Deferitazole

DB13120InvestigationalSmall molecule

Deferitazole is an iron chelator. It has been used in trials studying the treatment and basic science of Beta-thalassemia, Hepatic Impairment, Impaired Renal Function, Transfusional Iron Overload, and Iron Overload...

Formula / weight: C₁₈H₂₅NO₇S · 399.46 g/mol (avg)
Code names: FBS-0701 · SPD-602

Resolves to

Compound

UNII4D8DC53Y1LCAS945635-15-4ChEMBLCHEMBL487465PubChem16736198

Structure

InChIKeyAWHIMFSHNAAMBM-GOSISDBHSA-NSMILESCOCCOCCOCCOC1=C(O)C(=CC=C1)C1=N[C@](C)(CS1)C(O)=O

Targets

P69905HBA1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Deferitazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account